Jayagopal Ashwath 4

What Happened Jayagopal Ashwath, Chief Scientific & Development Officer of Opus Genetics, sold 7,542 shares on April 23, 2026, for a total of approximately $39,156. The weighted-average sale price was $5.19 per share (individual trades ranged from $5.18 to $5.21). The filing indicates this sale was an automatic disposition to satisfy tax withholding obligations related to the vesting/settlement of restricted stock units—not a discretionary, open-market trade made for investment reasons.

Key Details

• Transaction date: 2026-04-23; Form 4 filed: 2026-04-27 (filed within the typical two-business-day reporting window).
• Shares sold: 7,542; weighted-average price: $5.19; price range: $5.18–$5.21.
• Total proceeds: approximately $39,156.
• Ownership after transaction: not specified in the provided filing.
• Footnotes: F1 — sale was automatic for tax withholding (not a discretionary sale). F2 — weighted-average price shown; shares sold in multiple trades and the insider can provide per-trade breakdown on request.
• Transaction codes: S = sale; F (tax withholding) applies per footnote.

Context This was a non-discretionary, routine tax-withholding sale tied to RSU vesting. Such withholding sales are common and generally not treated as a signal about the insider’s view of the company’s prospects.